Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today
Portfolio Pulse from Henry Khederian
Vivos Therapeutics (NASDAQ:VVOS) shares fell 26.1% to $3.05 after announcing a $4.3 million registered offering of 1.36 million shares at $3.15 each. The offering, expected to close on September 20, will be managed by H.C. Wainwright & Co. and aims to raise funds for working capital and general corporate purposes.
September 19, 2024 | 2:37 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Vivos Therapeutics' stock dropped 26.1% following the announcement of a $4.3 million registered offering of 1.36 million shares at $3.15 per share. The offering is expected to close on September 20 and aims to raise funds for working capital and general corporate purposes.
The announcement of a registered offering typically leads to a dilution of existing shares, which can negatively impact the stock price. The 26.1% drop reflects investor concerns about dilution and the company's need for additional capital.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100